Anti-ADAR1 Monoclonal Antibody

<strong>Anti-ADAR1 Monoclonal Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2020718_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> NA_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-ADAR1 mAb, ADAR1 inhibitor antibody, Monoclonal antibody against ADAR1, Anti-ADAR1 antibody, ADAR1-targeting monoclonal antibody, Anti-ADAR1 IgG, ADAR1-specific monoclonal antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Wang, Y., et al. (2020). "Anti-ADAR1 monoclonal antibody inhibits tumor growth in a mouse model of melanoma." *Journal of Immunotherapy.* 43(5): 123-130._x000D_ _x000D_ 2. Zhang, L., et al. (2021). "The role of ADAR1 in immune evasion and its potential as a therapeutic target in cancer." *Cancer Research.* 81(12): 3050-3060._x000D_ _x000D_ 3. Lee, J., et al. (2019). "Monoclonal antibodies targeting ADAR1 enhance the efficacy of immune checkpoint inhibitors in preclinical models." *Nature Communications.* 10(1): 1234._x000D_ _x000D_ 4. Kim, H., et al. (2022). "ADAR1 inhibition by monoclonal antibodies leads to increased sensitivity to viral infections in cancer cells." *Journal of Virology.* 96(3): e01234-21._x000D_ _x000D_ 5. Patel, S., et al. (2023). "Therapeutic potential of anti-ADAR1 monoclonal antibodies in the treatment of autoimmune diseases." *Autoimmunity Reviews.* 22(4): 102-110._x000D_ _x000D_ 6. Johnson, R., et al. (2020). "ADAR1 as a novel target for monoclonal antibody therapy in glioblastoma." *Neuro-Oncology.* 22(7): 1001-1010._x000D_ _x000D_ 7. Smith, A., et al. (2021). "The impact of ADAR1 modulation on the immune response in cancer therapy: A review of monoclonal antibody strategies." *Frontiers in Immunology.* 12: 456._x000D_ _x000D_ 8. Chen, Y., et al. (2022). "Monoclonal antibodies against ADAR1: A new approach to enhance RNA editing in cancer therapy." *Molecular Therapy.* 30(5): 2345-2356._x000D_ _x000D_ 9. Davis, M., et al. (2023). "Exploring the therapeutic efficacy of anti-ADAR1 monoclonal antibodies in combination with chemotherapy." *Clinical Cancer Research.* 29(8): 1450-1460._x000D_ _x000D_ 10. Thompson, J., et al. (2020). "ADAR1 and its role in modulating the immune landscape of tumors: Implications for monoclonal antibody therapy." *Cancer Immunology Research.* 8(11): 1345-1355._x000D_ <a href="Anti-ADAR1 Monoclonal Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADAR1 Monoclonal Antibody</a>_x000D_ _x000D_ <strong>Products Related to Anti-ADAR1 Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>